Adaptimmune Therapeutics Plc ADR (NASDAQ: ADAP) open the trading on Thursday, with a bit cautious approach as it glided -37.65% to $0.28, before settling in
Adaptimmune Therapeutics Plc ADR (NASDAQ: ADAP) on Monday, plunged -6.23% from the previous trading day, before settling in for the closing price of $0.48. Within
Witnessing the stock’s movement on the chart, on Thursday, Adaptimmune Therapeutics Plc ADR (NASDAQ: ADAP) had a quiet start as it plunged -3.26% to $0.49,
On Monday, Adaptimmune Therapeutics Plc ADR (NASDAQ: ADAP) was -5.43% drop from the session before settling in for the closing price of $0.54. A 52-week
On Tuesday, Adaptimmune Therapeutics Plc ADR (NASDAQ: ADAP) was 3.69% up from the session before settling in for the closing price of $0.55. A 52-week
Adaptimmune Therapeutics Plc ADR (NASDAQ: ADAP) started the day on Thursday, with a price increase of 0.17% at $0.58, before settling in for the price
Newsdaemon.com is a Business and Stock news website that covers extensive information on Stock markets and Equities. One of the key emphases of this portal is to widen readers’ knowledge of public and private capital sharing, both in updates and broad analysis.
Copyright © 2024 News Daemon, All rights reserved.
